Cases 21 - 30 of 126
Actelion Pharmaceuticals US, Inc. et al v. Lupin Ltd. et al
as 1:2023cv00150
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd. and Nippon Shinyaku Co., Ltd.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
ZS Pharma, Inc. et al v. Lupin Limited et al
as 1:2022cv01055
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv01061
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2022cv00966
Plaintiff:
Vertex Pharmaceuticals Incorporated
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Avion Pharmaceuticals, LLC et al v. Lupin Limited et al
as 1:2022cv00729
Counter Defendant:
Avion Pharmaceuticals, LLC and Albion Laboratories, Inc.
Counter Claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv00639
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc. and Lupin Inc.
Counter Claimant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Lupin Limited et al
as 1:2022cv00637
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. and Sloan Kettering Institute for Cancer Research
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exeltis USA, Inc. et al v. Lupin Ltd. et al
as 1:2022cv00434
Counter Defendant:
Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and others
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
